First Turn Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
First Turn Management's TERN Position: Q2 2026 in Review
First Turn Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 326,694 shares — an estimated $17.2M sold.
First Turn Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $35.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.
- First Turn Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- First Turn Management sold 326,694 Terns Pharmaceuticals shares in Q2 2026, an estimated $17.2M.
- First Turn Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
- First Turn Management's Terns Pharmaceuticals position peaked at $35.2M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.
Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.